Tài liệu tham khảo |
Loại |
Chi tiết |
12. Adachi Y, Oshiro T, Okuyama T, et al (1995) "A simple classification of lymph node level in gastric carcinoma". The American journal of surgery, 169 (4), 382-385 |
Sách, tạp chí |
Tiêu đề: |
A simple classificationof lymph node level in gastric carcinoma |
|
13. Ba-Ssalamah A, Prokop M, Uffmann M, et al. (2003) "Dedicated multidetector CT of the stomach: spectrum of diseases". Radiographics, 23 (3), 44-625 |
Sách, tạp chí |
Tiêu đề: |
Dedicatedmultidetector CT of the stomach: spectrum of diseases |
|
14. Bittoni A, Maccaroni E, Scartozzi M, et al (2010) "Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives". European Review for Medical and Pharmacological Sciences, 14: 309-314 |
Sách, tạp chí |
Tiêu đề: |
Chemotherapy forlocally advanced and metastatic gastric cancer: state of the art andfuture perspectives |
|
15. Blakely AM, Miner TJ. (2013) "Surgical considerations in the treatment of gastric cancer". Gastroenterol Clin North Am., 42:337-57 |
Sách, tạp chí |
Tiêu đề: |
Surgical considerations in thetreatment of gastric cancer |
|
16. Blank S, Blaker H, Schaible A, et al, (2012) "Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients. ". Langenbeck's archives of surgery/Deutsche Gesellschaft furChirurgie, 397: 45–55 |
Sách, tạp chí |
Tiêu đề: |
Impact ofpretherapeutic routine clinical staging for the individualization oftreatment in gastric cancer patients |
|
17. Blank S, Lordick F, Dobritz M, et al., (2013) "A reliable risk score for stage IV esophagogastric cancer.". European journal of surgical oncology, 39: 823–830 |
Sách, tạp chí |
Tiêu đề: |
A reliable risk scorefor stage IV esophagogastric cancer |
|
18. Blank S, Stange A, Sisic L, et al. (2013) "Preoperative therapy of esophagogastric cancer: the problem of nonresponding patients. ".Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie 398: 211–220 |
Sách, tạp chí |
Tiêu đề: |
Preoperative therapy ofesophagogastric cancer: the problem of nonresponding patients |
|